science (rigerimod): for the treatment of lupus(rigerimod): for the treatment of lupus

address

ImmuPharma plc
50 Broadway
Westminster
London SW1H 0RG
U.K.
Telephone:+44 20 7152 4080
FAX:+44 20 7152 4001
E-mail: info@immupharma.com

get in touch

Note to patients: ImmuPharma's drug candidates are at an early stage of development and are not currently available for use by patients. If you are concerned that you may be affected by any of the conditions described on this website, please contact your family doctor for advice.

We would like to hear from you. Please use the most appropriate of the following contact details:

For investor enquiries: investors@immupharma.com
For potential corporate partnerships: business_development@immupharma.com
For career opportunities: careers@immupharma.com
For service providers, including conferences, market research, advertising and contract research: services@immupharma.com
Please do not contact us with unsolicited sales calls.

For all other general enquiries use the form below
 
Contact form submitted!
We will be in touch soon.